A mutation in the gene ELF4 likely set the stage for a teenage boy to develop immune thrombocytopenia (ITP), according to a new report. The…
Immune thrombocytopenia
Treatment with all-trans retinoic acid (ATRA), a compound derived from vitamin A, may help restore production of clot-promoting platelets in people with immune thrombocytopenia…
Blocking the activity of an enzyme known as MELK may help boost the production of platelets — tiny cell fragments that improve blood clotting and…
Regulatory authorities in Brazil have approved the oral therapy Tavalisse (fostamatinib disodium hexahydrate) for adults with chronic …
Spleen tyrosine kinase (SYK) inhibitors, including Tavalisse (fostamatinib disodium hexahydrate), may be effective treatments for adults with chronic primary ITP,…
Six people with treatment-resistant immune thrombocytopenia (ITP) and underlying systemic lupus erythematosus (SLE) all achieved clinical responses to CAR T-cell immunotherapy, according to a…
Takeda’s investigational therapy mezagitamab increased platelet counts in adults with persistent or chronic primary immune thrombocytopenia (ITP) in a Phase 2 trial,…
A woman with an extremely rare combination of three autoimmune diseases — immune thrombocytopenia (ITP), autoimmune hemolytic anemia (AIHA), and antiphospholipid syndrome — has been…
Oral dapsone, an antibiotic sometimes used in treatment-resistant cases, was linked to increased platelet counts in 58.6% of treated children, adolescents, and adults…
Pharma companies Galapagos and Gilead are in talks for a potential collaboration to develop gamgertamig, an experimental therapy for immune thrombocytopenia (ITP)…
